Bio-Techne Corp. buy UBS Group AG
Start price
05.02.26
/
50%
€56.00
Target price
05.02.27
-
Performance (%)
-20.21%
Price
13.03.26
€44.60
Summary
This prediction is currently active. The price of Bio-Techne Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.21%. Dividends of €0.080 are taken into consideration when calculating the performance. This prediction currently runs until 05.02.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Techne Corp. | -10.442% | -10.442% |
| iShares Core DAX® | -1.104% | -6.084% |
| iShares Nasdaq 100 | 0.328% | 2.327% |
| iShares Nikkei 225® | -1.082% | -7.987% |
| iShares S&P 500 | -0.055% | 0.880% |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for TECH provided by MarketBeat
Stopped prediction by UBS_Group_AG for Bio-Techne Corp.
Bio-Techne Corp.
Start price
Target price
Perf. (%)
€50.50
06.11.25
06.11.25
€60.82
06.11.26
06.11.26
-11.37%
13.03.26
13.03.26
